Higher‐dose glutathione therapy for Parkinson's disease in Japan: Is it really safe?
Identifieur interne : 001C53 ( Main/Exploration ); précédent : 001C52; suivant : 001C54Higher‐dose glutathione therapy for Parkinson's disease in Japan: Is it really safe?
Auteurs : Yutaka Naito [Japon] ; Ko Matsuo [Japon] ; Yasumasa Kokubo [Japon] ; Yugo Narita [Japon] ; Hidekazu Tomimoto [Japon]Source :
- Movement Disorders [ 0885-3185 ] ; 2010-05-15.
Descripteurs français
- Wicri :
- geographic : Japon.
English descriptors
- KwdEn :
- Aged, Antiparkinson Agents (administration & dosage), Antiparkinson Agents (adverse effects), Antiparkinson Agents (therapeutic use), Dose-Response Relationship, Drug, Drug Administration Schedule, Glutathione (administration & dosage), Glutathione (adverse effects), Glutathione (therapeutic use), Humans, Japan, Male, Parkinson Disease (drug therapy).
- MESH :
- chemical , administration & dosage : Antiparkinson Agents, Glutathione.
- chemical , adverse effects : Antiparkinson Agents, Glutathione.
- chemical , therapeutic use : Antiparkinson Agents, Glutathione.
- geographic : Japan.
- drug therapy : Parkinson Disease.
- Aged, Dose-Response Relationship, Drug, Drug Administration Schedule, Humans, Male.
Url:
DOI: 10.1002/mds.23022
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002735
- to stream Istex, to step Curation: 002735
- to stream Istex, to step Checkpoint: 000932
- to stream PubMed, to step Corpus: 001977
- to stream PubMed, to step Curation: 001977
- to stream PubMed, to step Checkpoint: 001849
- to stream Ncbi, to step Merge: 002A25
- to stream Ncbi, to step Curation: 002A25
- to stream Ncbi, to step Checkpoint: 002A25
- to stream Main, to step Merge: 002089
- to stream Main, to step Curation: 001C53
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Higher‐dose glutathione therapy for Parkinson's disease in Japan: Is it really safe?</title><author><name sortKey="Naito, Yutaka" sort="Naito, Yutaka" uniqKey="Naito Y" first="Yutaka" last="Naito">Yutaka Naito</name></author><author><name sortKey="Matsuo, Ko" sort="Matsuo, Ko" uniqKey="Matsuo K" first="Ko" last="Matsuo">Ko Matsuo</name></author><author><name sortKey="Kokubo, Yasumasa" sort="Kokubo, Yasumasa" uniqKey="Kokubo Y" first="Yasumasa" last="Kokubo">Yasumasa Kokubo</name></author><author><name sortKey="Narita, Yugo" sort="Narita, Yugo" uniqKey="Narita Y" first="Yugo" last="Narita">Yugo Narita</name></author><author><name sortKey="Tomimoto, Hidekazu" sort="Tomimoto, Hidekazu" uniqKey="Tomimoto H" first="Hidekazu" last="Tomimoto">Hidekazu Tomimoto</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9E2A36960F3AA7922C3C964F03FC6DE563DBAAAE</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1002/mds.23022</idno><idno type="url">https://api.istex.fr/document/9E2A36960F3AA7922C3C964F03FC6DE563DBAAAE/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002735</idno><idno type="wicri:Area/Istex/Curation">002735</idno><idno type="wicri:Area/Istex/Checkpoint">000932</idno><idno type="wicri:doubleKey">0885-3185:2010:Naito Y:higher:dose:glutathione</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:20131395</idno><idno type="wicri:Area/PubMed/Corpus">001977</idno><idno type="wicri:Area/PubMed/Curation">001977</idno><idno type="wicri:Area/PubMed/Checkpoint">001849</idno><idno type="wicri:Area/Ncbi/Merge">002A25</idno><idno type="wicri:Area/Ncbi/Curation">002A25</idno><idno type="wicri:Area/Ncbi/Checkpoint">002A25</idno><idno type="wicri:Area/Main/Merge">002089</idno><idno type="wicri:Area/Main/Curation">001C53</idno><idno type="wicri:Area/Main/Exploration">001C53</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Higher‐dose glutathione therapy for Parkinson's disease in Japan: Is it really safe?</title><author><name sortKey="Naito, Yutaka" sort="Naito, Yutaka" uniqKey="Naito Y" first="Yutaka" last="Naito">Yutaka Naito</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Mie University Graduate School of Medicine, Tsu</wicri:regionArea><wicri:noRegion>Tsu</wicri:noRegion></affiliation></author><author><name sortKey="Matsuo, Ko" sort="Matsuo, Ko" uniqKey="Matsuo K" first="Ko" last="Matsuo">Ko Matsuo</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Mie University Graduate School of Medicine, Tsu</wicri:regionArea><wicri:noRegion>Tsu</wicri:noRegion></affiliation></author><author><name sortKey="Kokubo, Yasumasa" sort="Kokubo, Yasumasa" uniqKey="Kokubo Y" first="Yasumasa" last="Kokubo">Yasumasa Kokubo</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Mie University Graduate School of Medicine, Tsu</wicri:regionArea><wicri:noRegion>Tsu</wicri:noRegion></affiliation></author><author><name sortKey="Narita, Yugo" sort="Narita, Yugo" uniqKey="Narita Y" first="Yugo" last="Narita">Yugo Narita</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Mie University Graduate School of Medicine, Tsu</wicri:regionArea><wicri:noRegion>Tsu</wicri:noRegion></affiliation></author><author><name sortKey="Tomimoto, Hidekazu" sort="Tomimoto, Hidekazu" uniqKey="Tomimoto H" first="Hidekazu" last="Tomimoto">Hidekazu Tomimoto</name><affiliation wicri:level="1"><country xml:lang="fr">Japon</country><wicri:regionArea>Department of Neurology, Mie University Graduate School of Medicine, Tsu</wicri:regionArea><wicri:noRegion>Tsu</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2010-05-15">2010-05-15</date><biblScope unit="vol">25</biblScope><biblScope unit="issue">7</biblScope><biblScope unit="page" from="962">962</biblScope><biblScope unit="page" to="962">962</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">9E2A36960F3AA7922C3C964F03FC6DE563DBAAAE</idno><idno type="DOI">10.1002/mds.23022</idno><idno type="ArticleID">MDS23022</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Antiparkinson Agents (administration & dosage)</term><term>Antiparkinson Agents (adverse effects)</term><term>Antiparkinson Agents (therapeutic use)</term><term>Dose-Response Relationship, Drug</term><term>Drug Administration Schedule</term><term>Glutathione (administration & dosage)</term><term>Glutathione (adverse effects)</term><term>Glutathione (therapeutic use)</term><term>Humans</term><term>Japan</term><term>Male</term><term>Parkinson Disease (drug therapy)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term><term>Glutathione</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term><term>Glutathione</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Glutathione</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Japan</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Dose-Response Relationship, Drug</term><term>Drug Administration Schedule</term><term>Humans</term><term>Male</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Japon</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader></TEI><affiliations><list><country><li>Japon</li></country></list><tree><country name="Japon"><noRegion><name sortKey="Naito, Yutaka" sort="Naito, Yutaka" uniqKey="Naito Y" first="Yutaka" last="Naito">Yutaka Naito</name></noRegion><name sortKey="Kokubo, Yasumasa" sort="Kokubo, Yasumasa" uniqKey="Kokubo Y" first="Yasumasa" last="Kokubo">Yasumasa Kokubo</name><name sortKey="Matsuo, Ko" sort="Matsuo, Ko" uniqKey="Matsuo K" first="Ko" last="Matsuo">Ko Matsuo</name><name sortKey="Narita, Yugo" sort="Narita, Yugo" uniqKey="Narita Y" first="Yugo" last="Narita">Yugo Narita</name><name sortKey="Tomimoto, Hidekazu" sort="Tomimoto, Hidekazu" uniqKey="Tomimoto H" first="Hidekazu" last="Tomimoto">Hidekazu Tomimoto</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C53 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001C53 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:9E2A36960F3AA7922C3C964F03FC6DE563DBAAAE
|texte= Higher‐dose glutathione therapy for Parkinson's disease in Japan: Is it really safe?
}}
| This area was generated with Dilib version V0.6.23. |  |